Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
University of Missouri-Columbia
Alexion Pharmaceuticals, Inc.
Amgen
Janssen Research & Development, LLC
AstraZeneca
Janssen Research & Development, LLC
UCB Pharma
AstraZeneca
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NMD Pharma A/S
Vor Biopharma
Immunovant Sciences GmbH
Janssen Research & Development, LLC
UCB Pharma
UCB Pharma
TG Therapeutics, Inc.
Arcellx, Inc.
Novartis
Ohio State University
Novartis
Alexion Pharmaceuticals, Inc.
argenx
argenx
argenx
argenx
Centre Hospitalier Universitaire de Nice
Cartesian Therapeutics
ImmunAbs Inc.
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
argenx
Novartis
Alexion Pharmaceuticals, Inc.
Tang-Du Hospital
Kyverna Therapeutics
Brain Inflammation Collaborative
Tongji Hospital
Fondation Ophtalmologique Adolphe de Rothschild
RemeGen Co., Ltd.